Dynamic mechanisms of non-classical antagonism by competitive AT1 receptor antagonists

被引:43
作者
Lew, MJ [1 ]
Ziogas, J [1 ]
Christopoulos, A [1 ]
机构
[1] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia
关键词
D O I
10.1016/S0165-6147(00)01523-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Selective competitive angiotensin AT(1) receptor antagonists exhibit diverse patterns of antagonism of angiotensin-II-mediated responses in functional assays. These range from the classical parallel rightward shift of agonist concentration-response curves with no depression of the maximum response to an apparently straightforward insurmountable antagonism with complete depression of the maximum response and no rightward shift. This article reviews some earlier equilibrium-based models that have been used to explain the insurmountable antagonism, and suggests that a kinetic model might provide a more satisfactory account of the observations. Such a model might provide deeper insights into the pharmacology of G-protein-coupled receptors than the more popular equilibrium models.
引用
收藏
页码:376 / 381
页数:6
相关论文
共 33 条
[1]   RECEPTOR-BINDING AND INTERNALIZATION OF A UNIQUE BIOLOGICALLY-ACTIVE ANGIOTENSIN-II COLLOIDAL GOLD CONJUGATE - MORPHOLOGICAL ANALYSIS OF ANGIOTENSIN-II PROCESSING IN ISOLATED VASCULAR STRIPS [J].
ANDERSON, KM ;
PEACH, MJ .
JOURNAL OF VASCULAR RESEARCH, 1994, 31 (01) :10-17
[2]   Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657 [J].
Aramori, I ;
Zenkoh, J ;
Morikawa, N ;
ODonnell, N ;
Asano, M ;
Nakamura, K ;
Iwami, M ;
Kojo, H ;
Notsu, Y .
MOLECULAR PHARMACOLOGY, 1997, 51 (02) :171-176
[3]  
BOND RA, 1989, J PHARMACOL EXP THER, V249, P401
[4]   Contractile effects by intracellular angiotensin II via receptors with a distinct pharmacological profile in rat aorta [J].
Brailoiu, E ;
Filipeanu, CM ;
Tica, A ;
Toma, CP ;
de Zeeuw, D ;
Nelemans, SA .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (05) :1133-1138
[5]   The assessment of antagonist potency under conditions of transient response kinetics [J].
Christopoulos, A ;
Parsons, AM ;
Lew, MJ ;
El-Fakahany, EE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 382 (03) :217-227
[6]   The cholecystokinin-B receptor antagonist L-740,093 produces an insurmountable antagonism of CCK-4 stimulated functional response in cells expressing the human CCK-B receptor [J].
Dunlop, J ;
Pass, I ;
Ennis, C .
NEUROPEPTIDES, 1998, 32 (02) :157-160
[7]   Insurmountable angiotensin AT1 receptor antagonists:: the role of tight antagonist binding [J].
Fierens, FLP ;
Vanderheyden, PML ;
De Backer, JP ;
Vauquelin, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 372 (02) :199-206
[8]   Action of AT1 receptor antagonists on angiotensin II-induced tone in human isolated subcutaneous resistance arteries [J].
Garcha, RS ;
Sever, PS ;
Hughes, AD .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (08) :1876-1882
[10]  
HATA T, 1982, EUR J CLIN PHARMACOL, V23, P7, DOI 10.1007/BF01061369